SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001641489-23-000079
Filing Date
2023-11-20
Accepted
2023-11-20 16:23:40
Documents
12
Period of Report
2023-11-20
Items
Item 8.01: Other Events

Document Format Files

Seq Description Document Type Size
1 8-K vtvt-20231120.htm   iXBRL 8-K 27697
  Complete submission text file 0001641489-23-000079.txt   153843

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT vtvt-20231120.xsd EX-101.SCH 1913
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT vtvt-20231120_lab.xml EX-101.LAB 23834
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT vtvt-20231120_pre.xml EX-101.PRE 12516
6 EXTRACTED XBRL INSTANCE DOCUMENT vtvt-20231120_htm.xml XML 2829
Mailing Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265
Business Address 3980 PREMIER DR SUITE 310 HIGH POINT NC 27265 336-841-0300
vTv Therapeutics Inc. (Filer) CIK: 0001641489 (see all company filings)

IRS No.: 473916571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37524 | Film No.: 231423081
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences